alendronate has been researched along with Fever in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report on a 35-year-old female who was diagnosed with TRAPS, after finding the V95M mutation on the TNFRSF1A gene; who was treated in order with etanercept, anakinra, and canakinumab (150 mg/every 8 weeks by subcutaneous injection, then increased to 150 mg every 4 weeks); and who started therapy with oral alendronate (70 mg/weekly) to control her osteoporosis." | 3.81 | Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. ( Cantarini, L; Frediani, B; Iannone, F; Lopalco, G; Rigante, D; Vitale, A, 2015) |
| "Alendronate is a potent bisphosphonate that has been studied for the treatment of osteoporosis and Paget's disease of the bone." | 2.69 | Pharmacokinetics of intravenous alendronate. ( Cocquyt, V; De Grève, J; DeSmet, M; Gertz, BJ; Holland, SD; Kline, WF; Porras, AG; Quan, H; Van Belle, SJ; Vyas, KP; Zhang, KE, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopalco, G | 1 |
| Rigante, D | 1 |
| Vitale, A | 1 |
| Frediani, B | 1 |
| Iannone, F | 1 |
| Cantarini, L | 1 |
| Cocquyt, V | 1 |
| Kline, WF | 1 |
| Gertz, BJ | 1 |
| Van Belle, SJ | 1 |
| Holland, SD | 1 |
| DeSmet, M | 1 |
| Quan, H | 1 |
| Vyas, KP | 1 |
| Zhang, KE | 1 |
| De Grève, J | 1 |
| Porras, AG | 1 |
1 trial available for alendronate and Fever
| Article | Year |
|---|---|
Pharmacokinetics of intravenous alendronate.
Topics: Adult; Aged; Alendronate; Animals; Area Under Curve; Carbon Radioisotopes; Cricetinae; Dose-Response | 1999 |
1 other study available for alendronate and Fever
| Article | Year |
|---|---|
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.
Topics: Adult; Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Therapy, Combina | 2015 |